Literature DB >> 6214580

Analysis of cloned T cell function. I. Dissection of cloned T cell proliferative responses using cyclosporin A.

C G Orosz, R K Fidelus, D C Roopenian, M B Widmer, R M Ferguson, F H Bach.   

Abstract

CsA interferes in a specific manner with the expansion of T cell clones in that it inhibits the antigen-driven component of the proliferative responses made by cloned helper T cells, cloned conventional cytolytic T cells, and cloned helper-independent cytolytic T cells. Cloned helper T cells and helper-independent cytolytic T cells, which share the ability to proliferate when cultured with specific alloantigen, fail to proliferate when cultured with specific alloantigen, fail to proliferate in response to this stimulus in the presence of CsA (10 to 100 ng/ml). In contrast, the proliferation observed when these cells are cultured with exogenous growth factors (but not alloantigen) is little influenced by as much as 1000 ng/ml CsA. When cloned helper T cells or helper-independent cytotoxic T cells are cultured with alloantigen plus exogenous growth factor, additive or synergistic proliferation occurs. However, CsA (10 to 1000 ng/ml) blocks only the component of proliferation induced by alloantigen, and leaves the lymphokine-driven component intact. CsA has similar effects on the proliferation of cloned conventional cytolytic T cells. Thus, CsA separates cloned T cell proliferation into two components: one driven by contact with alloantigens, the other driven by contact with mitogenic lymphokines.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6214580

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

Review 1.  The influence of cyclosporin A on cell-mediated immunity.

Authors:  A W Thomson; L M Webster
Journal:  Clin Exp Immunol       Date:  1988-03       Impact factor: 4.330

2.  Activation of antigen-specific suppressor T cells in the presence of cyclosporin requires interactions between T cells of inducer and suppressor lineage.

Authors:  N Mohagheghpour; C J Benike; G Kansas; C Bieber; E G Engleman
Journal:  J Clin Invest       Date:  1983-12       Impact factor: 14.808

Review 3.  Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders.

Authors:  Diana Faulds; Karen L Goa; Paul Benfield
Journal:  Drugs       Date:  1993-06       Impact factor: 9.546

4.  Recombinant interleukin 2 regulates levels of c-myc mRNA in a cloned murine T lymphocyte.

Authors:  J C Reed; D E Sabath; R G Hoover; M B Prystowsky
Journal:  Mol Cell Biol       Date:  1985-12       Impact factor: 4.272

5.  Cyclosporine affects the function of antigen-presenting cells.

Authors:  A M Varey; B R Champion; A Cooke
Journal:  Immunology       Date:  1986-01       Impact factor: 7.397

Review 6.  Cyclosporine: immunology, toxicity and pharmacology in experimental animals.

Authors:  A W Thomson; P H Whiting; J G Simpson
Journal:  Agents Actions       Date:  1984-10

7.  Selective suppression of an early step in human B cell activation by cyclosporin A.

Authors:  A Muraguchi; J L Butler; J H Kehrl; R J Falkoff; A S Fauci
Journal:  J Exp Med       Date:  1983-09-01       Impact factor: 14.307

8.  Suppressor T cell growth and differentiation. Identification of a cofactor required for suppressor T cell function and distinct from interleukin 2.

Authors:  S Rich; M R Carpino; C Arhelger
Journal:  J Exp Med       Date:  1984-05-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.